Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc.
TypePublic
IndustryPharmaceuticals
HeadquartersBoston, Massachusetts, U.S.
Key peopleTom Riga (CEO)
RevenueDecrease US$109.33 million (2018)
Owner
  • Assertio Holdings
  • (2023–present)
Number of employees
Increase 164 (December 31, 2021)
Websitesppirx.com

Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology.

After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based company on July 31.